Genprex, Inc. Files 8-K: Corporate Details & Financials

Ticker: GNPX · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1595248

Sentiment: neutral

Topics: corporate-filing, financials, pharmaceuticals

Related Tickers: GNPX

TL;DR

Genprex (GNPX) filed an 8-K on 4/28 detailing corporate info and financials.

AI Summary

Genprex, Inc. filed an 8-K on April 28, 2025, reporting other events and financial statements. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (December 31). Genprex, Inc. is located in Austin, Texas, and operates in the pharmaceutical preparations industry.

Why It Matters

This filing provides essential corporate and financial information for Genprex, Inc., which is crucial for investors and stakeholders to understand the company's structure and reporting status.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure and does not contain significant new operational or financial risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Genprex, Inc.?

The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of April 28, 2025.

In which state was Genprex, Inc. incorporated?

Genprex, Inc. was incorporated in Delaware.

What is the fiscal year end for Genprex, Inc.?

The fiscal year end for Genprex, Inc. is December 31.

What is the business address of Genprex, Inc.?

The business address of Genprex, Inc. is 3300 Bee Cave Road, #650-227, Austin, TX 78746.

What is the SIC code for Genprex, Inc.?

The Standard Industrial Classification (SIC) code for Genprex, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Genprex, Inc. (GNPX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing